These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 28189814)
1. Optimization of paeonol-loaded poly(butyl-2-cyanoacrylate) nanocapsules by central composite design with response surface methodology together with the antibacterial properties. Yao J; Zhang Y; Hu Q; Zeng D; Hua F; Meng W; Wang W; Bao GH Eur J Pharm Sci; 2017 Apr; 101():189-199. PubMed ID: 28189814 [TBL] [Abstract][Full Text] [Related]
2. Effect of solvents on forming poly(butyl-2-cyanoacrylate) encapsulated paeonol nanocapsules. Yao J; Zeng D; Zhang Y; Sun D; Yang E; Liu H; Guo F; Wang W J Biomater Sci Polym Ed; 2017 Feb; 28(3):240-256. PubMed ID: 27846779 [TBL] [Abstract][Full Text] [Related]
3. Optimization of paeonol-loaded microparticle formulation by response surface methodology. Li SS; Li GF; Liu L; Li H; Jiang X; Li XL; Liu ZG; Zuo T; Weng LD; Liu Q J Microencapsul; 2015; 32(7):677-86. PubMed ID: 26225493 [TBL] [Abstract][Full Text] [Related]
4. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres. Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657 [TBL] [Abstract][Full Text] [Related]
5. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration. Miyazaki S; Takahashi A; Kubo W; Bachynsky J; Löebenberg R J Pharm Pharm Sci; 2003; 6(2):238-45. PubMed ID: 12935436 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Chen ZX; Li B; Liu T; Wang X; Zhu Y; Wang L; Wang XH; Niu X; Xiao Y; Sun Q Eur J Pharm Sci; 2017 Mar; 99():240-245. PubMed ID: 28039091 [TBL] [Abstract][Full Text] [Related]
7. Formulation of liposomes gels of paeonol for transdermal drug delivery by Box-Behnken statistical design. Shi J; Ma F; Wang X; Wang F; Liao H J Liposome Res; 2012 Dec; 22(4):270-8. PubMed ID: 22676370 [TBL] [Abstract][Full Text] [Related]
8. Optimized preparation of celastrol-loaded polymeric nanomicelles using rotatable central composite design and response surface methodology. Peng X; Wang J; Song H; Cui D; Li L; Li J; Lin L; Zhou J; Liu Y J Biomed Nanotechnol; 2012 Jun; 8(3):491-9. PubMed ID: 22764419 [TBL] [Abstract][Full Text] [Related]
9. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles. Jin X; Huang A; Ping Q; Cao F; Su Z Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of anti-VEGF antibody-modified liposomes loaded with paeonol in the prevention and treatment of hypertrophic scars. Shi J; Wu Y; Guo S; Zhang H; Chen G; Xu X Drug Dev Ind Pharm; 2019 Mar; 45(3):439-455. PubMed ID: 30512972 [TBL] [Abstract][Full Text] [Related]
11. Paeonol-loaded PLGA nanoparticles as an oral drug delivery system: Design, optimization and evaluation. Wang F; Shan Q; Chang X; Li Z; Gui S Int J Pharm; 2021 Jun; 602():120617. PubMed ID: 33887394 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use. Limayem Blouza I; Charcosset C; Sfar S; Fessi H Int J Pharm; 2006 Nov; 325(1-2):124-31. PubMed ID: 16872764 [TBL] [Abstract][Full Text] [Related]
15. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
16. PEGylated niosomes-mediated drug delivery systems for Paeonol: preparation, pharmacokinetics studies and synergistic anti-tumor effects with 5-FU. He RX; Ye X; Li R; Chen W; Ge T; Huang TQ; Nie XJ; Chen HJ; Peng DY; Chen WD J Liposome Res; 2017 Jun; 27(2):161-170. PubMed ID: 27184460 [TBL] [Abstract][Full Text] [Related]
17. Paeonol-Loaded Ethosomes as Transdermal Delivery Carriers: Design, Preparation and Evaluation. Ma H; Guo D; Fan Y; Wang J; Cheng J; Zhang X Molecules; 2018 Jul; 23(7):. PubMed ID: 30018278 [TBL] [Abstract][Full Text] [Related]
18. Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: preparation, physicochemical properties and cytotoxicity. Yordanov G; Skrobanska R; Evangelatov A Colloids Surf B Biointerfaces; 2013 Jan; 101():215-22. PubMed ID: 23010022 [TBL] [Abstract][Full Text] [Related]
19. Poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion polymerization. 2. PEG-based surfactants. Wu M; Dellacherie E; Durand A; Marie E Colloids Surf B Biointerfaces; 2009 Feb; 69(1):147-51. PubMed ID: 19027270 [TBL] [Abstract][Full Text] [Related]
20. Development and characterization of novel highly-loaded itraconazole poly(butyl cyanoacrylate) polymeric nanoparticles. Ćurić A; Möschwitzer JP; Fricker G Eur J Pharm Biopharm; 2017 May; 114():175-185. PubMed ID: 28159723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]